Vitamin E has no role in cataract prevention

Article

Vitamin E supplements do not help to prevent cataract, according to a study published in the May 2008 issue of Ophthalmology.

Vitamin E supplements do not help to prevent cataract, according to a study published in the May 2008 issue of Ophthalmology.

William G. Christen, ScD of Brigham and Women's Hospital, Boston, US and colleagues analyzed data from the Women's Health Study (WHS), an ongoing, 10-year randomized controlled study evaluating the effects of vitamin E and low-dose aspirin in primary prevention of cardiovascular disease and cancer in apparently healthy women.

Professional women aged ≥45 years at baseline (n=39,876) took 100 mg of aspirin daily and 600 IU of vitamin E every other day for up to six and a half years. Health, lifestyle and cataract history of the women was also noted. Women taking the vitamin E supplements were found to have rates of cataract development comparable to women who did not take supplements, even amongst those women (smokers, diabetic) who would have been expected to respond well to antioxidant vitamin treatment.

Dr Christen concluded that, at least in the short-term, vitamin E supplements have no role in cataract prevention.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.